Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × INDUSTRY × Vancomycin × Clear all

Phase

Phase 3 2 Phase 4 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 249 Paclitaxel 172 Carboplatin 164 Gemcitabine 138 Cisplatin 120 Docetaxel 117 Cyclophosphamide 117 Nivolumab 109 Bevacizumab 102 Injections 91 Dexamethasone 80 fludarabine 79 atezolizumab 77 Cetuximab 76 Pemetrexed 73 Fluorouracil 68 venetoclax 65 Irinotecan 62 Rituximab 60 Capecitabine 59 Azacitidine 58 130-nm albumin-bound paclitaxel 54 Leucovorin 50 Lenalidomide 50 Ipilimumab 49 Fulvestrant 49 Oxaliplatin 48 Trastuzumab 46 durvalumab 45 Erlotinib Hydrochloride 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06540391 2025-09-26

MELODY-1

Microbiotica Ltd

Phase 1 Active not recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡